CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
PRNewswire New Delhi [India], July 13: As China continues to gain attention for advanced oncology treatments including cancer gene therapy, CAR-T cell therapy, immunotherapy, advanced radiotherapy…
Read the full articleYou might also wanna read
CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
The country’s new regulatory pathway promises to accelerate access to advanced therapies for Chinese patients, but may change the licensing
biopharmadive.com·1mo ago
China approves world's first CAR-T cell therapy for solid tumors: CARsgen's satri-cel for advanced gastric cancer
The gastric cancer treatment proves engineered cellular therapies can treat solid tumors.
insideprecisionmedicine.com·21d ago企業數位轉型治理框架：從戰略規劃到執行落地的系統性方法論
深度解析企業數位轉型治理框架：涵蓋 COBIT、ISO 38500、TOGAF 等國際標準比較，董事會層級監督機制、資料治理基礎建設、變革管理與組織設計、KPI 衡量方法論，以及 AI 整合策略，為企業領導者提供從戰略規劃到執行落地的系統性方法論。
A Non-interventional, Real-world Study on the Adjuvant Treatment of Chinese EGFR-positive Stage IA NSCLC Patients With High-risk Factors Using Third-generation EGFR-TKIs.
Conditions : Non-Small Cell Lung Cancer; Adjuvant Therapy Interventions : Drug: Third-generation EGFR-TKI Sponsors : First Affiliated Hospit
Comments
Sign in to join the conversation.
No comments yet. Be the first.